Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 539

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 2
Chunk 539
---
 objectives. These performance objectives
and areas of emphasis were used as a guide by the Compensation Committee and Board of Directors in determining overall corporate performance
for these executives as they represented those areas in which they were expected to focus their efforts during the year. Both qualitative
and quantitative guidelines were established for purposes of evaluating performance relating to these corporate objectives during 2024.
Based on its review of our overall performance relative to our corporate objectives, the Compensation Committee determined that every
goal was achieved or exceeded for annual bonus plan purposes.

The
overall achievement level was then used to determine each named executive officer’s bonus. The bonuses paid to our named executive
officers for 2024 are set forth in the “Summary Compensation Table” above.

Equity
Compensation

The
goals of our long-term, equity-based incentive awards are to align the interests of our named executive officers and other employees,
non-employee directors and consultants with the interests of our stockholders. Because vesting is based on continued employment, our
equity-based incentives also encourage the retention of our named executive officers through the vesting period of the awards. In determining
the size of the long-term equity incentives to be awarded to our named executive officers, we take into account a number of internal
factors, such as the relative job scope, the value of existing long-term incentive awards, individual performance history, prior contributions
to us and the size of prior grants.

To
reward and retain our named executive officers in a manner that best aligns employees’ interests with stockholders’ interests,
we use stock options as the primary incentive vehicles for long-term compensation. We believe that stock options are an effective tool
for meeting our compensation goal of increasing long-term stockholder value by tying the value of the stock options to our future performance.
Because employees are able to profit from stock options only if our stock price increases relative to the stock option’s exercise
price, we believe stock options provide meaningful incentives to employees to achieve increases in the value of our stock over time.

The
exercise price of each stock option grant is the fair market value of our common stock on the grant date, as determined by our Board
of Directors from time to time. Stock option awards granted to our named executive officers generally vest as to one-third of the total
shares on the first anniversary of the grant date and thereafter the remaining shares vest in equal quarterly installments over the following
24 months. From time to time, our Compensation Committee may, however, determine that a different vesting schedule